Neoadjuvant Serplulimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced, Resectable Esophagogastric Junction Adenocarcinoma.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined